AAM names 2023 board of directorsChristine Baeder, senior vice president and chief operating officer for U.S. generics, Teva Pharmaceuticals USA is the 2023 AAM chair of the board. Ahold Delhaize’s efforts to provide low prices impacts Q4The retail conglomerate reported that group net sales increased by 8.1% at constant exchange rates and up 15.9% at actual exchange rates. Teva to pay Florida $6.73M to settle state’s price fixing claims Teva will pay Florida $6.73 million, and the state will dismiss all of its claims against the company and its affiliates once payment has been made. People on the move … Feb. 10 Important personnel changes you should know this week about Walmart, The Pharmaceutical Research and Manufacturers of America and more. Lupin receives tentative nod from FDA for DETAF DETAF would be used for the management of HIV infections and will be available for low- and middle-income countries. Alvotech, Advanz Pharma enter commercialization agreement for Xolair biosimilar Omalizumab is used to treat patients with allergic asthma, chronic spontaneous urticaria and nasal polyps. Amazon posts strong Q4, full year results Amazon’s North American segment reported that its sales increased 13% year-over-year to $93.4 billion. Walgreens Boots Alliance reportedly weighing $2B sale of pharmacy automation unit iA Walgreens Boots Alliance is weighing a sale of pharmacy automation provider iA, according to a report. AmerisourceBergen changes name to Cencora The new name represents a unified presence that will continue to fuel the company’s ongoing growth strategy and advance its impact across health care. Amneal forms partnership with Orion The collaboration is aimed at bringing Amneal generic products to market in Europe, Australia and New Zealand. First Previous 21 22 23 24 25 Next Last
